London stocks subdued as Brexit fears offset first vaccine approval

Dec 2 Reuters Londonlisted shares were muted on Wednesday as fears about a nodeal Brexit overshadowed news that the UK had become the worlds first country to approve the PfizerBioNTech COVID19 vaccine.

The bluechip FTSE 100 was flat and the midcap FTSE 250 down 0.4 even as the government said the vaccine would be rolled out from early next week.

The FTSE 100 had rallied more than 12 in November, marking its best month in 31 years, on optimism that a COVID19 vaccine would soon be available.

Investor attention this week has squarely been on Brexit negotiations with only weeks left for Britains transition agreement to expire.

A senior British minister said there was still a chance of nodeal Brexit as talks had snagged on fishing, governance rules and dispute resolution.

In company news, security group G4S jumped 7 after Canadas GardaWorld raised its offer for the British company, valuing it at 3.68 billion pounds

4.94 billion.

Reporting by Shivani Kumaresan in Bengaluru; Editing by Subhranshu Sahu

Source Reuters

What's your reaction?

In Love
Not Sure

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:News